88.00PLN+12.10%Mkt Cap: 817.22M PLNP/E: —Last update: 2026-06-03
Medinice S.A., a medical technology company, creates, develops, and commercializes minimally invasive solutions in cardiology and cardiac surgery. The company offers PacePress, a medical device to reduce the risk of comp…
Industry Peers
Medical Devices151.52BUSDP/E 24.4
113.09BUSDP/E 34.1
70.88BUSDP/E 20.0
55.03BSEKP/E 102.7
52.39BDKKP/E 22.2
51.45BSEKP/E 21.8
49.52BUSDP/E 46.5
38.78BEURP/E 18.3
Indicators:|
Key Statistics
Company
Market Cap817.22M PLN
Enterprise Value660.33M PLN
Revenue (TTM)—
Gross Profit-166.00K PLN
Net Income (TTM)-6.72M PLN
Revenue/Share—
Last Price88.00 PLN
Fiscal Year EndDec 2025
MR QuarterDec 2025
Employees—
CountryPL
SectorHealthcare
IndustryMedical Devices
ISINPLMDNCE00016
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA-98.82
EV/Revenue—
P/S—
P/B7.45
EPS (TTM)-0.86
EPS (Forward)—
52W Range
6.740100% of range88.00
52W High88.00 PLN
52W Low6.740 PLN
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-7.63%
ROA-7.25%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-5.58M PLN
CapEx (TTM)6.07M PLN
FCF Margin—
FCF Yield-1.09%
Net Debt-9.24M PLN
Net Debt/EBITDA1.38
Balance Sheet
Debt/Equity0.00
Current Ratio6.87
Quick Ratio6.85
Book Value/Sh9.673 PLN
Cash/Share1.034 PLN
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 PLN
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.9.29M
Float5.77M
Insiders22.49%
Institutions15.48%
Technical
SMA 5063.77 (+38.0%)
SMA 20030.63 (+187.3%)
Beta1.16
S&P 52W Chg27.94%
Avg Vol (30d)54.61K
Avg Vol (10d)38.06K
Technical Indicators
RSI (14)70.8
MACD3.8573
MACD Signal3.2993
MACD Hist.+0.5580
BB Upper82.31 PLN
BB Middle73.91 PLN
BB Lower65.51 PLN
BB Width22.73%
ATR (14)4.682 PLN
Vol Ratio (20d)3.80x